Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
By restraining T‐cell activation and promoting Treg‐cell expansion, myeloid‐derived suppressor cells (MDSCs) and tolerogenic DCs can control self‐reactive and antigraft effector T cells in autoimmunity and transplantation. Their therapeutic use and characterization, however, is limited by their scarce availability in the peripheral blood of tumor‐free donors. In the present study, we describe and characterize a novel population of human myeloid suppressor cells, named fibrocytic MDSC, which are differentiated from umbilical cord blood precursors by 4‐day culture with FDA‐approved cytokines (recombinant human‐GM‐CSF and recombinant human‐G‐CSF). This MDSC subset, characterized by the expression of MDSC‐, DC‐, and fibrocyte‐associated markers, promotes Treg‐cell expansion and induces normoglycemia in a xenogeneic mouse model of Type 1 diabetes. In order to exert their protolerogenic function, fibrocytic MDSCs require direct contact with activated T cells, which leads to the production and secretion of IDO. This new myeloid subset may have an important role in the in vitro and in vivo production of Treg cells for the treatment of autoimmune diseases, and in either the prevention or control of allograft rejection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They promote regulatory T cell (Treg) expansion and restrain T-cell activation (117)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [117]
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Self-citationEvolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636435 · Cited by 1,011
Research works printed but not linked: 1
- 10.1158/0008-5472.can-07-6621 · DOI · Paper page
Cited by
Items 101–129 of 129
Zhang, S., Dai, Q., Zhang, B., Liu, S. M., Wang, Y., Zhang, Y., Chen, D., Zong, N., Wang, H., Ding, J., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3329 · Cited by 7
“Generally, MDSCs and tolerogenic DCs can effectively inhibit the proliferation of self-reactive and antigraft effector T cells in autoimmunity and transplantation by restraining T-cell activation and promoting Treg expansion (33-35).”
BackgroundAlhajahjeh, A. A., Stahl, M. F., Kim, T. K., Kewan, T. Z., Stempel, J. M., Zeidan, A. M., & Bewersdorf, J. P. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2483855 · Cited by 7
“Recent studies have also identified additional subtypes, such as fibrocytic MDSCs (F-MDSCs), observed in patients with sarcoma and in umbilical cord blood [71,72].”
Zhang, S., Zhao, G., Su, C., Li, C., Zhou, X., Zhao, W., Zhong, Y., He, Z., Peng, H., Dong, A., et al. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1671134 · Cited by 6
Insights on Peptide Vaccines in Cancer Immunotherapy
Tsang, K. Y., Jochéms, C., & Schlom, J. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-21167-1_1 · Cited by 6
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma
Kerboeuf, M., Anfinsen, K. P., Koppang, E. O., Lingaas, F., Argyle, D. J., Teige, J., Sævik, B. K., & Moe, L. (2024) · Veterinary and Comparative Oncology · doi:10.1111/vco.13026 · Cited by 4
Role of myeloid cells in the tumor microenvironment
Balakrishnan, A., Vig, M., & Dubey, S. (2022) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.33 · Cited by 4
Tumor-Induced Myeloid-Derived Suppressor Cells
Sanctis, F. D., Bronte, V., & Ugel, S. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch49 · Cited by 4
Self-citationProgress in research on the role played by myeloid‐derived suppressor cells in liver diseases
Sun, Q.-Q., Dai, H., Wang, S., Chen, Y., & Shi, H. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13312 · Cited by 2
Content of myeloid-derived suppressor cells in autoimmune diseases in children
Радыгина, Т. В., Купцова, Д. Г., Petrichuk, S. V., Потапов, А. С., Murashkin, N. N., Abdullaeva, L. М., Курбатова, О. В., & Tsvetkova, V. S. (2023) · Russian Journal of Immunology · doi:10.46235/1028-7221-10044-com · Cited by 2
Role of Myeloid-Derived Suppressor Cells and Regulatory T-Cells in the Tuberculous Granuloma
Cheung, L. S., Srikrishna, G., & Bishai, W. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-25381-3_4 · Cited by 2
Metabolic reprogramming and immunity in cancer
Chen, Y., & Li, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00006-5 · Cited by 2
Knowing the myeloid-derived suppressor cells: Another enemy of sarcomas patients
García-Domínguez, D. J., Sánchez‐Margalet, V., de la Cruz‐Merino, L., & Hontecillas‐Prieto, L. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2022.11.003 · Cited by 2
Lipid peroxidation and superoxide dismutase activity in pea seedlings under clinorotation.
Бараненко, В. В. (1998) · PubMed · Cited by 2
Leporati, M., Genaro, M. S. D., & Eliçabe, R. J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1440514 · Cited by 1
Role and Therapeutic Implications of MDSCs in Sarcomas
Lala, B., Kalbasi, A. K., & Singh, A. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-93530-0_1 · Cited by 1
Reversing Breast Cancer-Induced Immune Suppression
Beury, D. W., & Ostrand‐Rosenberg, S. (2013) · Defense Technical Information Center (DTIC) · doi:10.21236/ada573503
T Cell Fate in the Tumor Microenvironment
Crespo, J., Kryczek, I., Welling, T. H., Wei, S., & Zou, W. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-21167-1_3
Unique pattern of PMN-MDSC migration in cancer
Patel, S., Condamine, T., Dominguez, G., Partlova, S., Languino, L. R., Vonderheide, R. H., & Gabrilovich, D. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.196.supp.119.8
Blandinières, A. (2018) · theses.fr (ABES) · doi:10.70675/9178d6fcz7e4ez48deza1dcz0840f8c96b22
Re, G. L., Doretto, P., Re, F. L., Matrone, F., Ermacora, A., Marus, W., Pizzichetta, M. A., & Sulfaro, S. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.11
“This scenario becomes permissive to the immunosuppression exercised above all by Tregs and MDSCs, as well as by tumor-associated macrophages. cSCC shows a high tumor mutation burden (TMB), a condition that makes immunotherapy effectiveness highly possible.”
InfluentialModulation of Myeloid-Derived Suppressor Cells Amplification by Tumor Microenvironment
张, 瑞. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.1111741
Joseph, E. L. M. (2019) · theses.fr (ABES) · doi:10.70675/bba1a27bz36bdz488cza60azf58fa2e47702
Kosmaczewska, A., Przeździecka-Dołyk, J., Ciszak, L., Rojek-Gajda, Z., Frydecka, I., Turno‐Kręcicka, A., Misiuk‐Hojło, M., & Pawlak, E. (2025) · Cells · doi:10.3390/cells14201636
Li, R., Zhao, A., Yan, C., Li, B., & Hao, Z. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003940
May, C. G. (2024) · cIRcle (University of British Columbia) · doi:10.14288/1.0438573
Cellules suppressives d'origine myéloïde au cours du sepsis
Uhel, F. (2016) · theses.fr (ABES) · doi:10.70675/df0db2b6zf5d0z48eczbd5dz2914bac94168 · Cited by 1
Avsharian, L. C., Loganathan, S., Ebelt, N. D., Ruggiero-Ruff, R. E., Salcido, S., Inal, S. E., Nair, M. G., & Manuel, E. R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792483
Metadata
- Authors
- Zoso, A., Mazza, E. M. C., Bicciato, S., Mandruzzato, S., Bronte, V., Serafini, P., & Inverardi, L.
- Affiliations
- University of Miami (US)
- University of Modena and Reggio Emilia (IT)
- University of Padua (IT)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Corresponding author
- Serafini, Paolo
- Inverardi, Luca
- ORCID
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2014-10-18
- Volume
- 44
- Issue
- 11
- Pages
- 3307-3319
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1893750616
- Cited by
- 123
- References
- 46
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 15 · 2021: 17 · 2020: 9 · 2019: 11 · 2018: 10 · 2017: 8 · 2016: 13 · 2015: 11 · 2014: 1
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Flight Attendant Medical Research Institute
- Susan G. Komen for the Cure
- Diabetes Research & Wellness Foundation
- Diabetes Research Foundation
- FIRB
- Foundation for Diabetes Research
- Frank Strick Foundation
- Stacy Joy Goodman Memorial Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- myeloid-derived suppressor cells, indoleamine 2,3-dioxygenase, regulatory T cells, Treg cell expansion, type 1 diabetes, normoglycemia, tolerogenic dendritic cells, T cell tolerance, allograft rejection, autoimmune disease, GM-CSF, granulocyte colony-stimulating factor, xenograft models
- MeSH terms
- Animals, Cell Differentiation, Cell Line, Diabetes Mellitus, Type 1, Female, Fetal Blood, Graft Rejection, Humans, Immune Tolerance, Lymphocyte Activation, Recombinant Proteins, Granulocyte-Macrophage Colony-Stimulating Factor, Mice, SCID, Mice, Inbred NOD, Gene Expression Profiling, Myeloid Cells, Cell Proliferation, T-Lymphocytes, Regulatory, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.